Tower Research Capital LLC (Trc) Fennec Pharmaceuticals Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,624 shares of FENC stock, worth $13,154. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,624
Previous 6,460
74.86%
Holding current value
$13,154
Previous $53,000
73.58%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding FENC
# of Institutions
87Shares Held
14.2MCall Options Held
10KPut Options Held
83.8K-
Southpoint Capital Advisors LP New York, NY4.08MShares$33 Million1.08% of portfolio
-
Sonic Gp LLC Honolulu, HI2.41MShares$19.5 Million33.54% of portfolio
-
Solas Capital Management, LLC Darien, CT2.19MShares$17.7 Million14.46% of portfolio
-
Black Rock Inc. New York, NY1.19MShares$9.62 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA956KShares$7.74 Million0.0% of portfolio
About FENNEC PHARMACEUTICALS INC.
- Ticker FENC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,067,300
- Market Cap $211M
- Description
- Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...